Heat denaturation, a simple method to improve the immunotherapeutic potential of allergens (Q81474067)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16285011%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Heat denaturation, a simple method to improve the immunotherapeutic potential of allergens (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16285011%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

6

Thomas M Kündig

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16285011%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Pål Johansen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16285011%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Gabriela Senti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16285011%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Julia Maria Martínez Gómez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16285011%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Brunello Wüthrich

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16285011%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Adrian Bot

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16285011%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 December 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16285011%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16285011%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16285011%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16285011%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

3591-3598

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16285011%20AND%20SRC:MED&resulttype=core&format=json

Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Long-term clinical efficacy of grass-pollen immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

On T cell memory: arguments for antigen dependence

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Memory B-cell persistence is independent of persisting immunizing antigen.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

B-cell memory is short-lived in the absence of antigen.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Toll-like receptors and immune response in allergic disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Airway peptidoglycan and immunostimulatory DNA exposures have divergent effects on the development of airway allergen hypersensitivities

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Antigen-independent suppression of the allergic immune response to bee venom phospholipase A(2) by DNA vaccination in CBA/J mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Generation of an allergy vaccine by disruption of the three-dimensional structure of the cross-reactive calcium-binding allergen, Phl p 7.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

From allergen structure to new forms of allergen-specific immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Native Art v 1 and recombinant Art v 1 are able to induce humoral and T cell-mediated in vitro and in vivo responses in mugwort allergy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

In vitro and in vivo allergenicity of recombinant Bet v 1 compared to the reactivity of natural birch pollen extract

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

A double-blind placebo-controlled evaluation of sublingual immunotherapy with a standardized ragweed extract in patients with seasonal rhinitis. Evidence for a dose-response relationship

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Allergen immunotherapy with cat allergen peptides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Allergen-derived long peptide immunotherapy down-regulates specific IgE response and protects from anaphylaxis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Polymerization of mixtures of grass allergens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Changes in the antigenic and immunoglobulin E-binding properties of hen's egg albumin with the combination of heat and gamma irradiation treatment

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Class I chitinases, the panallergens responsible for the latex-fruit syndrome, are induced by ethylene treatment and inactivated by heating

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Effect of heat-induced aggregation on the IgE binding of patatin (Sol t 1) is dominated by other potato proteins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

In vivo histamine release during the first minutes after deliberate sting challenges correlates with the severity of allergic symptoms

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Biological characterization of glutaraldehyde-modified Parietaria judaica pollen extracts

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Genetic engineering of allergens: future therapeutic products

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Heat denaturation affects the ProDer p 1 IgE reactivity and downregulates the development of the specific allergic response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

TGF-beta-mediated control of allergen-specific T-cell responses.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Is TGF-beta1 the key to suppression of human asthma?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Mechanism of IL-10-induced T cell inactivation in allergic inflammation and normal response to allergens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Immunity in response to particulate antigen-delivery systems

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

In vivo kinetics of the immunoglobulin E response to allergen: bystander effect of coimmunization and relationship with anaphylaxis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Direct intralymphatic injection of peptide vaccines enhances immunogenicity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535076

7 January 2021

Identifiers

DOI

10.1002/EJI.200535076

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16285011%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference